Fact-checked by Grok 2 weeks ago

Toxic granulation

Toxic granulation is a distinctive morphological abnormality observed in the cytoplasm of neutrophils on peripheral blood smears, characterized by the presence of dark, coarse, azurophilic granules that indicate an activated state of these white blood cells in response to infection or inflammation.^[1]^[2] This feature contrasts with the normal light pink or neutral-staining granules in resting neutrophils and is typically detected through light microscopy of stained blood samples.^[3] In clinical hematology, toxic granulation arises as part of a broader reactive process in neutrophils, often accompanying other changes such as Döhle bodies (small, pale blue inclusions in the cytoplasm), cytoplasmic vacuolization, and a left shift toward immature band forms or earlier precursors.^[1]^[2] It is most commonly triggered by acute bacterial infections, including sepsis, where the severity of granulation correlates with the intensity of the inflammatory response, as neutrophils rapidly produce and release antimicrobial substances from their granules.^[2] Chronic inflammatory conditions, such as rheumatoid arthritis or inflammatory bowel disease, can also induce this phenomenon, reflecting ongoing immune activation.^[1] The clinical significance of toxic granulation lies in its role as a rapid, qualitative indicator of systemic inflammation or infection, often appearing alongside neutrophilia (an elevated neutrophil count above 7,700 cells per microliter) and leukocytosis.^[1] While not pathognomonic for any single disease, its detection prompts further diagnostic evaluation, such as cultures or imaging, to identify and treat the underlying cause, thereby aiding in the timely management of potentially life-threatening conditions like severe bacterial sepsis.^[2] In laboratory practice, automated analyzers may flag potential toxic granulation through parameters like neutrophil granularity indices, but confirmation requires manual smear review for accuracy.^[1]

Definition and Overview

Definition

Toxic granulation refers to the presence of large, coarse, dark-staining granules in the cytoplasm of granulocytes, primarily neutrophils, bands, and metamyelocytes, as observed in peripheral blood smears.^[4] These granules are azurophilic or basophilic in nature and appear as prominent purple or dark blue structures when stained with Wright-Giemsa, distinguishing them from the finer, less conspicuous granules in normal neutrophils.^[4] This morphological change represents a non-specific reactive phenomenon occurring during accelerated granulopoiesis, triggered by physiological stress rather than direct toxicity from pathogens.^[5]^[6] The "toxic" designation reflects the granules' intense staining rather than any inherent poisonous quality, highlighting the bone marrow's rapid production of neutrophils in response to demand.^[7] In severe cases, such as intense inflammatory states, toxic granulation may be prominent in neutrophils, though prevalence varies with the underlying condition and staining technique.^[8]

Historical Context

Toxic granulation was first described in hematology literature during the early 20th century, particularly in studies examining blood alterations associated with severe infections in the 1920s and 1930s. These observations highlighted prominent cytoplasmic granules in neutrophils from patients with sepsis and other inflammatory conditions. The term "toxic granulation" was coined by Swiss pathologist Otto Naegeli in his 1931 monograph Blutkrankheiten und Blutdiagnostik to characterize these coarse, darkly staining granules as indicative of toxicity in granulocytes during infectious states.^[9] Early interpretations viewed toxic granulation as a direct result of bacterial toxins or pathogens impairing neutrophil function, a perspective dominant in the pre-1950s era when light microscopy was the primary tool for analysis. This understanding evolved significantly with the advent of electron microscopy in the mid-20th century. Studies in the 1960s and 1970s, including ultrastructural examinations of neutrophils from patients with bacterial infections, demonstrated that the granules represent exaggerated primary (azurophilic) granules due to accelerated bone marrow maturation driven by inflammatory cytokines, rather than direct cellular poisoning.^[10] A pivotal milestone in the recognition of toxic granulation occurred with its formal inclusion in standardized hematology reference materials. For instance, guidelines from the College of American Pathologists (CAP) defined it as the presence of large, purple to dark blue cytoplasmic granules in neutrophils, bands, and metamyelocytes that exceed the size and staining intensity of normal granules, aiding consistent morphological identification in clinical practice.^[11]

Morphology and Appearance

Microscopic Characteristics

Toxic granules are observed under light microscopy in Romanowsky-stained blood smears as coarse, prominent structures within the neutrophil cytoplasm.^[11] They appear coarser and darker than normal secondary granules, staining intensely purple to blue-black due to their azurophilic nature.^[12]^[13] In severe cases, the granules are so abundant that they may obscure the nucleus.^[13] These granules are predominantly distributed in the cytoplasm of mature neutrophils, as well as immature forms including bands and metamyelocytes.^[14] Their number varies from a few scattered granules to numerous ones that can cover 50-100% of the cytoplasm in severe inflammatory states.^[13] Toxic granulation is assessed semi-quantitatively in laboratory reports using a grading system: mild (scattered granules with minimal involvement), moderate (numerous granules without obscuring nuclear details), and severe (dense granules that mask the nucleus).^[15]

Associated Cellular Changes

Toxic granulation in neutrophils is frequently accompanied by other morphological alterations, including Döhle bodies, toxic vacuolization, and cytoplasmic basophilia, which collectively reflect accelerated bone marrow production and activation during inflammatory states. Döhle bodies appear as pale blue, round to linear inclusions in the cytoplasm, composed of aggregated rough endoplasmic reticulum rich in RNA, often located peripherally in the cell. Toxic vacuolization manifests as clear or frothy cytoplasmic vacuoles resulting from phagocytic activity and lysosomal degranulation, while cytoplasmic basophilia presents as a diffuse blue tint due to increased polyribosomes and rough endoplasmic reticulum, indicating heightened synthetic activity.^[11]^[16]^[15] These changes exhibit varying prevalence and patterns depending on the underlying condition, with all features signaling a left shift in neutrophil maturation characterized by increased immature forms such as bands and metamyelocytes. Döhle bodies are observed in approximately 10-20% of affected neutrophils in inflammatory responses, appearing earlier than other toxic features and persisting in conditions like severe infections. Toxic vacuolization is more prominent in bacterial infections, occurring in up to 30% of neutrophils in sepsis cases, often correlating with the intensity of systemic inflammation. Cytoplasmic basophilia tends to be diffuse and streak-like, accompanying the other changes in a majority of reactive neutrophilias but without specific quantitative prevalence widely reported.^[17]^[18]^[15] The combination of toxic granulation, toxic vacuolization, and Döhle bodies—often termed the "toxic changes" triad—is a hallmark of severe sepsis, observed in a substantial proportion of cases according to laboratory studies, with toxic granules present in over 50%, vacuoles in about 30%, and Döhle bodies in 15-20% of neutrophils in affected patients. This triad, alongside a left shift, enhances diagnostic specificity for bacterial sepsis over non-infectious inflammation, though individual features may occur independently.^[17]^[19]^[16]

Pathophysiology

Etiology

Toxic granulation in neutrophils primarily arises from infectious causes, with bacterial infections being the most frequent trigger. Severe bacterial infections, such as sepsis caused by Staphylococcus aureus or Escherichia coli, are commonly associated, occurring in approximately 75% of sepsis cases where neutrophils exhibit this feature.^[20]^[21] Viral infections, including COVID-19 and influenza, can also induce toxic granulation through neutrophil activation and cytokine release, though less prominently than bacterial causes.^[22]^[23] Fungal infections like candidiasis have been linked to marked toxic granulation in neutrophils, often in systemic cases such as candidemia.^[24] Non-infectious triggers include various inflammatory disorders, such as rheumatoid arthritis, where neutrophil activation leads to granule alterations amid chronic inflammation. Burns and tissue damage from trauma or surgery provoke toxic granulation via heightened cytokine responses and systemic stress.^[14] Malignancies, particularly those involving inflammation like leukemia, can present with toxic granulation in neutrophils, reflecting reactive changes rather than direct neoplastic effects.^[25] Drug reactions, especially from chemotherapy agents, induce this morphology through cytotoxic effects on granulopoiesis.^[26] Risk factors for toxic granulation encompass systemic inflammation in hospitalized patients, observed in up to 75% of those with sepsis or similar conditions.^[20] The feature typically resolves upon effective treatment of the underlying cause, often within days as inflammatory markers normalize.^[27]

Formation Mechanisms

Toxic granulation arises primarily from accelerated granulopoiesis in the bone marrow, where intense inflammatory stimuli shorten the normal neutrophil maturation time of approximately 10-14 days to 4-6 days, leading to incomplete cytoplasmic development and persistence of primary azurophilic granules into mature stages.^[15]^[28] This rapid production, known as emergency granulopoiesis, causes a left shift in neutrophil release, with immature forms retaining prominent azurophilic granules due to asynchrony between nuclear segmentation and granule remodeling.^[29] The incomplete degranulation prevents the typical loss of these early-stage granules, resulting in their abnormal prominence in circulating neutrophils.^[15] At the molecular level, cytokines such as granulocyte colony-stimulating factor (G-CSF) and interleukin-6 (IL-6) drive this process by stimulating progenitor proliferation and differentiation, upregulating transcription factors like C/EBPβ to promote a shift toward immature neutrophil output and granule retention.^[29]^[30] G-CSF, in particular, enhances bone marrow release of both mature and immature neutrophils, while IL-6 cooperates to amplify the inflammatory response, ensuring heightened granule production without full maturation.^[29] These factors collectively alter granulopoiesis dynamics, favoring quantity over complete refinement of granule content.^[31] Electron microscopy reveals that toxic granules correspond to large, electron-dense, peroxidase-positive structures akin to primary azurophilic granules, exhibiting high enzyme density without evidence of direct bacterial incorporation.^[10] Inflammation induces lysosomal labilization, increasing alkaline phosphatase activity and forming autophagic vacuoles, which reflect altered Golgi-derived granule packaging rather than fusion events.^[10] These ultrastructural changes underscore the bone marrow's adaptive response to stress, prioritizing rapid deployment of functional neutrophils.^[15]

Biochemical Composition

Granule Components

Toxic granules in neutrophils originate from azurophilic (primary) granules, which are specialized lysosome-like organelles formed during the promyelocyte stage of granulopoiesis and filled with antimicrobial and proteolytic proteins. These granules contain high levels of myeloperoxidase (MPO), comprising approximately 5% of the neutrophil's dry weight or total protein content, along with neutrophil elastase, cathepsin G, α-defensins (such as human neutrophil peptides), and lysozyme. MPO is the most abundant protein in these granules, serving as a key marker for their identification, while elastase and cathepsin G are serine proteases, and defensins and lysozyme provide direct microbicidal activity.^[32]^[33]^[34] In the context of toxic granulation, these azurophilic granules exhibit increased prominence and density, with elevated MPO concentrations—up to several times normal levels due to accelerated granule formation and fusion during stress responses—correlating directly with the degree of toxic granulation observed. This structural organization supports the compact storage of their protein cargo.^[35]^[32]^[36] The characteristic dark purple staining of toxic granules in Romanowsky-type preparations, such as Wright-Giemsa, arises from their azurophilic properties, due to the affinity of their cationic protein contents for the basic dye components (such as azure B and methylene blue).^[37]^[35]

Functional Properties

Toxic granulation in neutrophils signifies an activated state characterized by enhanced antimicrobial capabilities, primarily through the increased prominence, synthesis, and activity of azurophilic granules containing key enzymes such as myeloperoxidase (MPO), elastase, and cathepsin G.^[38] MPO, abundant in these granules, catalyzes the production of hypochlorous acid (HOCl) from hydrogen peroxide and chloride ions, a potent oxidant that directly kills bacteria by damaging their proteins, lipids, and DNA.^[39] Similarly, elastase and cathepsin G, serine proteases stored in the same granules, contribute to bacterial killing by degrading microbial proteins and cell walls, thereby disrupting pathogen integrity within the phagosome.^[40] Overall, these toxic granules bolster bactericidal properties by acidifying the granule environment through mucosubstances, creating an optimal milieu for enzymatic and oxidative attacks on engulfed pathogens.^[19] In addition to direct microbial destruction, toxic granulation supports heightened phagocytosis efficiency in inflamed conditions, allowing neutrophils to more rapidly engulf and process infectious agents. This activation phenotype, marked by toxic granules, enables quicker phagosome-granule fusion, delivering antimicrobial cargoes intracellularly to enhance pathogen clearance without excessive extracellular release.^[34] The functional properties of toxic granules also extend to inflammatory modulation, where degranulation releases components that amplify the immune response but may exacerbate tissue damage in prolonged inflammation. Granule-derived proteins, including those from azurophilic stores, stimulate the production of proinflammatory cytokines such as TNF-α from surrounding immune cells, thereby recruiting additional effectors and intensifying the local inflammatory cascade.^[41] However, this unchecked release in chronic scenarios can promote oxidative stress and proteolysis of host tissues, contributing to pathological outcomes like organ dysfunction.^[42] From an adaptive perspective, toxic granulation represents a primed state in neutrophils, retaining hyperdense granules that facilitate swift deployment of defenses upon secondary stimulation. This priming increases the capacity for oxidative burst, generating reactive oxygen species more robustly to combat infection.^[43] By extending neutrophil lifespan and enhancing bactericidal readiness through colony-stimulating factors, toxic granules provide a strategic advantage in acute infections, allowing faster resolution of threats.^[19]

Clinical Aspects

Diagnostic Significance

Toxic granulation is primarily detected in clinical laboratory settings through manual microscopic examination of a peripheral blood smear stained with Wright-Giemsa or similar Romanowsky stains, where a technologist reviews approximately 100-200 white blood cells across multiple fields to identify neutrophils exhibiting prominent dark blue to purple cytoplasmic granules.^[44]^[6] This qualitative assessment grades the granulation as mild (1+), moderate (2+), or severe (3+ to 4+) based on granule prominence and the proportion of affected neutrophils, often in conjunction with other reactive changes like Döhle bodies or cytoplasmic vacuolization. Automated hematology analyzers, such as the Sysmex XE-5000, provide supportive screening by calculating a granularity index (GI) that measures increased neutrophil granularity due to prominent primary granule content, flagging samples with elevated immature granulocyte parameters for manual confirmation; however, these instruments cannot fully replace microscopy for accurate identification.^[45] In interpretive guidelines, the presence of toxic granulation in a significant proportion of neutrophils (often graded as 2+ or higher) signals acute inflammatory or infectious processes, particularly bacterial sepsis, when combined with neutrophilia (absolute neutrophil count exceeding 7,700/μL) and a left shift toward immature forms.^[46]^[47] This constellation enhances diagnostic specificity for infection over sterile inflammation, as levels of toxic granulation correlate positively with serum C-reactive protein concentrations in affected patients.^[48] Nonetheless, the finding must be contextualized with clinical symptoms, as isolated toxic granulation lacks high sensitivity for pinpointing etiology. Limitations include its non-specific nature, as toxic granulation appears in diverse conditions such as trauma, burns, or malignancy-related inflammation.^[15] False positives can arise from technical artifacts, including improper staining, prolonged sample storage in EDTA tubes leading to pseudo-granulation, or over-fixation effects that mimic granule prominence.^[15] These factors underscore the need for prompt sample processing and correlation with automated flags to minimize interpretive errors.

Prognostic Value

Toxic granulation in neutrophils is associated with disease severity in conditions such as sepsis, where the extent and intensity of granulation reflect the magnitude of inflammatory response and bacterial burden. Severe toxic granulation, characterized by dense granules in a substantial proportion of neutrophils (often >50%), correlates with more intense systemic inflammation and higher inflammatory markers like C-reactive protein and procalcitonin, indicating greater risk of complications. In contrast, mild toxic granulation, involving scattered granules in fewer neutrophils, typically resolves with appropriate antimicrobial therapy without leading to long-term sequelae.^[49]^[50] The persistence of toxic granulation beyond the acute phase of infection serves as an outcome predictor, suggesting inadequate response to therapy and continued immune dysregulation, which is linked to poorer prognosis including increased complications and mortality in sepsis patients. When combined with other neutrophil changes such as vacuolization, persistent toxic granulation amplifies the risk of adverse outcomes by highlighting sustained neutrophil activation. Studies emphasize that severe or unresolved toxic granulation is a marker of high-risk cases, though specific quantitative risks vary by patient cohort.^[50]^[49] Longitudinal assessment via serial blood smears enables tracking of toxic granulation resolution, with normalization of neutrophil morphology indicating effective treatment and improved prognosis in critically ill patients.^[49]

Differential Diagnosis

Similar Conditions

Pseudo-toxic granulation arises as an artifact from suboptimal blood smear preparation or staining techniques, such as thick smears resulting in uneven distribution of stain, leading to apparent coarse cytoplasmic granulation in neutrophils that mimics true toxic changes.^[51] This pseudogranulation is non-pathologic and typically resolves upon preparation of a fresh smear or re-staining with optimized conditions, distinguishing it from genuine inflammatory responses.^[15] Several inherited or acquired neutrophil anomalies can morphologically resemble toxic granulation but differ in granule characteristics, distribution, and clinical context. The Alder-Reilly anomaly, an autosomal recessive disorder often linked to mucopolysaccharidoses, features coarse, lilac-colored azurophilic granules present in neutrophils, eosinophils, basophils, monocytes, and lymphocytes, in contrast to the coarser, dark blue-black granules confined primarily to neutrophils in toxic granulation.^[52] Unlike toxic granulation, which accompanies acute inflammation and may include Döhle bodies or left shift, Alder-Reilly granules persist lifelong without associated neutrophilia or functional impairment.^[38] Chediak-Higashi syndrome, a rare autosomal recessive lysosomal trafficking disorder, is characterized by giant, fused azurophilic granules in granulocytes, monocytes, lymphocytes, and other cells, which are fewer in number and larger than the numerous small-to-medium dark granules seen in toxic granulation.^[53] These oversized granules result from defective lysosomal fusion and are accompanied by systemic features like partial albinism, recurrent infections, and neurological deficits, setting the condition apart from reactive toxic changes limited to neutrophils.^[38] In myelodysplastic syndromes, hypergranulation manifests as irregular, dysplastic granules in neutrophils, often alongside hypogranulation, pseudo-Pelger-Huët nuclei, or other multilineage dysplasia, reflecting clonal hematopoietic defects rather than the uniform, reactive hypergranulation of toxic changes.^[54] These dysplastic features arise from ineffective granulopoiesis and are typically persistent, unlike the transient nature of toxic granulation in inflammatory states.^[54] Such mimicking conditions are uncommon overall; artifacts from smear preparation affect a notable proportion of routine laboratory analyses, while genetic disorders like Alder-Reilly anomaly and Chediak-Higashi syndrome have incidences below 1 in 100,000 live births.^[51]^[53]

Distinguishing Criteria

Toxic granulation is distinguished from inherited conditions like the Alder-Reilly anomaly primarily by its acquired and transient nature, often linked to acute infections or inflammatory states, whereas Alder-Reilly anomaly is a lifelong, autosomal recessive feature associated with mucopolysaccharidoses and positive family history.^[55] In Alder-Reilly anomaly, coarse azurophilic granules appear uniformly across neutrophils, lymphocytes, and monocytes without accompanying Döhle bodies, left shift, or neutrophilia, contrasting with the variable involvement and associated immature forms typically seen in toxic granulation.^[55] Diagnostic tools such as flow cytometry can quantify myeloperoxidase (MPO) levels, which are elevated in toxic granulation due to accelerated granule production, aiding differentiation from MPO-normal inherited anomalies.^[35] Genetic testing, including enzyme assays or mutation analysis for genes like those in mucopolysaccharidoses (e.g., IDS for Hunter syndrome) or LYST for Chediak-Higashi syndrome, confirms syndromic causes when granules mimic toxic changes.^[55]^[56] Clinical correlation is essential; absence of inflammation or infection effectively rules out toxic granulation, as seen in artifacts or non-inflammatory states.^[15] Electron microscopy further refines identification: toxic granules exhibit large, electron-dense cores that are peroxidase-positive, distinguishable from the giant, fused lysosomal structures with heterogeneous content in Chediak-Higashi syndrome.^[10] In practice, monitoring response to therapy provides a key differentiator; toxic granulation resolves rapidly upon treatment of the underlying infection, often within days as inflammatory markers normalize, whereas dysplastic granulation in myelodysplastic syndromes persists despite anti-infective interventions and requires bone marrow evaluation for confirmation.^[57] Artifacts, such as improper staining, lack the left shift and clinical context of true toxic changes, emphasizing the need for repeat smears and correlation with patient history.^[58]

References

[1]
Neutrophilia - StatPearls - NCBI Bookshelf - NIH
The presence of toxic granulations and Dohle bodies can also be seen in various infectious and inflammatory states. Granulomatous diseases are characterized by ...
[2]
The clinical value of hematological neutrophil and monocyte ... - NIH
After neutrophils are activated, a series of morphological changes will occur, including the appearance of toxic granulation, vacuolization, and Dohle bodies, ...
[3]
Elementary Hematology - Medical Laboratory Science - UW Oshkosh
The cytoplasm of a neutrophil is light pink. When a person is fighting infection, the granules may be dark colored. This is called toxic granulation. One type ...
[4]
[PDF] Hematology and Clinical Microscopy Glossary - 2024
Apr 14, 2021 · Toxic granulation is defined by the presence of large, purple or dark blue cytoplasmic granules in neutrophils, bands, and metamyelocytes.
[5]
Peripheral Blood Smear - Clinical Methods - NCBI Bookshelf - NIH
Toxic granulation, a rather nonspecific finding, is found in a variety of disorders including infections and metabolic derangements. Döhle bodies are seen ...
[6]
Abdominal, Thoracic, and Pericardial Effusions - PMC
Toxic changes (i.e., Döhle bodies, toxic granulation, diffuse cytoplasmic ... accelerated granulopoiesis caused by inflammation. Toxic neutrophils in ...<|control11|><|separator|>
[7]
Neutrophils with Toxic Granulation Show High Fluorescence with ...
Toxic granules are dark blue to purple intra-cytoplasmic granules in neutrophils, and are found during acute bacterial infections or other toxic conditions [1].
[8]
Differential white blood cell count: underutilized or overrated
... toxic granulation (20%) suggests a severe infection well handled; and a falling total leukocyte count with a relatively great increase in the immature ...<|control11|><|separator|>
[9]
https://www.toxicdocs.org/d/onNbmJ9bDgrV6G7rnY0EG4Rr
[10]
LYSOSOMAL AND ULTRASTRUCTURAL CHANGES IN HUMAN ...
These observations suggest that toxic granules represent an abnormal staining reaction of the large dense granules in the toxic cells, and not phagocytized ...Missing: artifact | Show results with:artifact
[11]
[PDF] Hematology and Clinical Microscopy Glossary
Toxic changes in neutrophils include toxic granulation, toxic vacuolization, and Döhle ... Toxic granulation and Döhle bodies each may be present in an individual ...
[12]
Toxic Granulation - The Blood Project
Aug 22, 2021 · Toxic granulation is the presence of large purple or dark blue cytoplasmic granules (primary granules) in neutrophils, bands, and metamyelocytes.
[13]
Reactive neutrophilia - Pathology Outlines
Feb 10, 2023 · Reactive neutrophilia, as seen in infections, usually demonstrates toxic granulation, Döhle bodies and cytoplasmic vacuolization.
[14]
Toxic granulation - ASH Image Bank
Mar 24, 2023 · Toxic granulation is the presence of large basophilic or azurophilic cytoplasmic granules in neutrophils, bands, and metamyelocytes.
[15]
Toxic change | eClinpath
Toxic granulation: These are distinct red granules in the cytoplasm due to the primary granules taking up stain. This is a rarely seen feature in domestic ...Missing: 20%
[16]
Lysosomal and ultrastructural changes in human "toxic" neutrophils ...
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med. 1969 Feb 1;129(2):267-93. doi: 10.1084/jem.129.2 ...
[17]
Morphological changes in white blood cells in systemic inflammatory ...
The presence of toxic granules and cytoplasmic vacuoles in the neutrophils of patients with SIRS with sepsis was significantly more common, compared to patients ...
[18]
Complete Blood Count in Primary Care - bpacnz
In a severe infection the neutrophils may show toxic granulation and other toxic changes such as vacuolation and the presence of Döhle bodies. Neutrophils ...
[19]
Toxic granules in neutrophils in sepsis patients: Does it really helpful?
Lysosomal and ultrastructural changes in human “toxic”neutrophils during bacterial infection. J Exp Med 1969;129:267–93. Cited Here |; PubMed | CrossRef ...
[20]
Chapter 19: Inflammation - Clinical Laboratory Diagnostics
Granulocytes with toxic granulation are present in approximately three quarters of patients with sepsis but this is not specific for sepsis /21/. Tissue ...
[21]
Sepsis and Septic Shock
These infections can lead to sepsis, with the most common cause being E coli. ... Neutrophils may contain toxic granulations, Döhle bodies, or cytoplasmic ...
[22]
Coronavirus disease 2019 (COVID‐19): Focus on peripheral blood ...
Oct 6, 2022 · Besides a left shift in maturation, granulations can be increased (toxic type) or decreased with areas of basophilia. Nuclei are often ...
[23]
Neutrophils in respiratory viral infections | Mucosal Immunology
Mar 23, 2021 · Neutrophil activation can trigger degranulation whereby neutrophils secrete mediators and proteolytic enzymes such as MMPs, MPO, and NE, which ...
[24]
Intraleukocytic Yeast Inclusions and Toxic Granulation Neutrophils ...
We describe two occasional findings of neutrophil inclusions and toxic granulation neutrophils (TGNs) respectively due to Candida tropicalis and Candida ...Missing: specific | Show results with:specific<|separator|>
[25]
Granulocytes in Helminth Infection - Who is Calling the Shots? - PMC
Release of toxic molecules, such as elastase and hydrogen peroxide is an important mechanism that efficiently kills the parasites, as has been demonstrated for ...
[26]
The role of the neutrophil in rheumatoid arthritis - PubMed
Exposure to immune complexes, rheumatoid factor, and cytokines in the synovial fluid results in neutrophil activation with release of granule contents, toxic ...
[27]
Chronic neutrophilic leukemia: new science and new diagnostic ...
Feb 13, 2018 · Neutrophil toxic granulations and Dohle bodies are a common finding in CNL and may be suggestive of an activated neutrophil state. It is of ...
[28]
Toxic granulation – Knowledge and References - Taylor & Francis
Toxic granulation refers to the presence of abnormal granules in white blood cells, which can be observed in cases of severe inflammation, infection, and drug ...
[29]
Serum Procalcitonin and Neutrophil Toxic Granules Guided ...
Toxic granules disappeared when serum PCT levels reached < 1 ng/mL. The patient responded well to treatment and he was discharged on the 16th day upon request.
[30]
A kinetic model of bone marrow neutrophil production that ...
Postmitotic maturation time, which accounts for 6–8 days under basal conditions (14), is reduced by 3–4 days during active neutrophil recruitment (13, 19, 37), ...
[31]
The Ontogeny of a Neutrophil: Mechanisms of Granulopoiesis and ...
Here we detail neutrophil ontogeny, granulopoiesis, and neutrophil homeostasis and highlight important differences between neonatal and adult neutrophil ...Hematopoiesis · Granulopoiesis · Neutrophil Granules And...
[32]
C/EBPβ isoforms sequentially regulate regenerating mouse ...
Jul 28, 2020 · C/EBPα and C/EBPβ are involved in the regulation of steady state and emergency granulopoiesis, respectively. C/EBPα restricts the proliferation ...
[33]
Regulation of emergency granulopoiesis during infection - Frontiers
These cells do not generate neutrophils by themselves but secrete hematopoietic cytokines (such as G-CSF, IL-6) which indirectly influence differentiation and ...
[34]
Granules of the Human Neutrophilic Polymorphonuclear Leukocyte
The rare condition termed specific granule deficiency is characterized by defects in expression of defensins and of matrix proteins of specific granules, but ...Classification Of Neutrophil... · Specific Functions Of... · Targeting Of Proteins To...
[35]
Myeloperoxidase is required for neutrophil extracellular trap formation
Introduction. Myeloperoxidase (MPO) is one of the most abundant proteins in neutrophils, accounting for 5% of the dry weight of the cell.
[36]
Roles of neutrophil granule proteins in orchestrating inflammation ...
Neutrophil granules can fuse with the nascent phagosome, releasing their cargo into the vacuole to destroy ingested pathogens or with the plasma membrane, ...
[37]
The relationship of myeloperoxidase activity to neutrophil maturity ...
The correlation coefficients were statistically significant for increased MPO activity with band count, toxic granulation, and the Schilling Index; however ...
[38]
[PDF] ORIGIN OF GRANULES IN POLYMORPHONUCLEAR ...
forms shows a regular crystalline lattice structure with a repeating period of ~-~1500 A. Abbreviations for Figures. G, Golgi complex ag, azurophil granule.<|control11|><|separator|>
[39]
Neutrophil Granule - an overview | ScienceDirect Topics
Primary granules are related to lysosomes and contain myeloperoxidase (MPO); ... primary granules, produces hypochlorous acid, a highly toxic microbicidal agent.
[40]
Toxic Granulation - an overview | ScienceDirect Topics
Toxic granulation is defined as the presence of larger, darkly staining granules in the cytoplasm of neutrophils, indicating possible underlying infections, ...
[41]
The Role of Myeloperoxidase in Biomolecule Modification, Chronic ...
MPO produces hypochlorous acid (HOCl) and other strong oxidants, which kill bacteria and other invading pathogens. However, MPO also drives the development of ...
[42]
Roles of neutrophil granule proteins in orchestrating inflammation ...
Mar 8, 2021 · They contain a large number of antimicrobial proteins, including MPO, serine proteases (elastase, proteinase 3, cathepsin G, and azurocidin), α- ...Granule formation and... · Biological roles of granule... · Granule constituents and...
[43]
Neutrophils in chronic inflammatory diseases - Nature
Jan 17, 2022 · However, neutrophil granule proteins and NETs can promote macrophage activation and proinflammatory cytokine secretion, exacerbating ...Missing: toxic | Show results with:toxic
[44]
Cell intrinsic functions of neutrophils and their manipulation by ... - NIH
The efficacy of this response impacts antimicrobial activity, but can also cause tissue damage if granules are instead exocytosed at the plasma membrane.Missing: properties | Show results with:properties
[45]
Multiple Phenotypic Changes Define Neutrophil Priming - Frontiers
Specific and azurophilic granules, which contain toxic anti-microbial components, undergo the most limited exocytosis. An in vivo study showed that neutrophils ...
[46]
https://www.aafp.org/pubs/afp/issues/2015/1201/p1004.html
[47]
Granularity Index of the SYSMEX XE-5000 hematology analyzer as ...
May 17, 2011 · The SYSMEX XE-5000 is an automated hematology analyzer, which can measure toxic granulation of TGNs by calculating the Granularity (GI) Index.
[48]
Evaluation of Patients with Leukocytosis - AAFP
Dec 1, 2015 · The peripheral smear should be examined for toxic granulations (suggestive of inflammation), platelet clumps (which may be misinterpreted as ...
[49]
Approach to the patient with neutrophilia - UpToDate
Jun 28, 2024 · Thus, the threshold for neutrophilia in most clinical laboratories is approximately 7700/microL (11,000 WBC/microL x 70 percent). Normal values ...
[50]
Toxic Granulation of Neutrophils | Test Findings - MedSchool
Causes of Toxic Granulation. Bacterial infection; Inflammation; G-CSF; Pregnancy; Recovery post bone marrow suppression.
[51]
Toxic Granulation - ASH Image Bank
Sep 17, 2015 · Toxic granulation in neutrophils is found in inflammatory states. The toxic granules are azurophilic, and may be found in the promyelocyte, metamyelocyte, band.Missing: μm | Show results with:μm
[52]
[PDF] Toxic granulations: a key marker in sepsis Granulaciones tóxicas
Only original and recent studies addressing the clinical, diagnostic, and prognostic features of toxic granulation in patients with sepsis were selected ...<|control11|><|separator|>
[53]
Recognize the Significance of Detecting Toxic Granules in Sepsis
Recent studies have reviewed the significance of recognizing toxic granulation in neutrophils, a critical morphological change in sepsis, reflecting the ...
[54]
Artifacts that may be present on a blood film - ResearchGate
Aug 7, 2025 · Many artifacts or pseudoartifacts may be noted during the examination of a blood film. Artifactual results also may be generated by ...<|control11|><|separator|>
[55]
Nonmalignant leukocyte disorders - PMC - PubMed Central - NIH
Toxic granulation can mimic granulation found in Alder-Reilly anomaly. One helpful defining characteristic of toxic granulation is that in most cases, not ...
[56]
Chediak-Higashi Syndrome - StatPearls - NCBI Bookshelf - NIH
The exact prevalence is unknown. There have been fewer than 500 cases worldwide that have been reported in the literature. It is difficult to determine the ...
[57]
How I investigate dysgranulopoiesis - Shekhar - Wiley Online Library
May 25, 2021 · Dysgranulopoiesis is a condition in which granulocytic production is defective and is most often described in neoplastic conditions.
[58]
Alder Reilly Anomaly: Types, Causes, Treatment & Prevention
Jun 28, 2025 · Alder-Reilly anomaly is a rare, inherited genetic ... Genetic testing can also be used to identify mutations associated with MPS disorders.<|separator|>
[59]
Giant granules of neutrophils in Chediak-Higashi syndrome are ...
We have examined the ultrastructure and mobilization of neutrophil granules from a patient with CHS by immunogold electron microscopy and exocytosis experiments ...
[60]
Chapter 8 – Myelodysplastic Syndromes | Oncohema Key
Jan 4, 2021 · One of the most important distinctions is to differentiate between MDS ... MDS are often hypogranulated, but only seldom show toxic granulation.
[61]
Left shift | eClinpath
If there is moderate to severe toxic change in neutrophils and no left shift, then there is a problem with cell identification or cells are not toxic but are ...